Michael Briley
4Patents
3h-index
5Co-inventors
36Inventor score
Filing activity: Jun 29, 1995 → Mar 26, 1997
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5726177A | Indole-derived arylpiperazines as ligands for 5HT.sub.1 -like, 5HT.sub.1B and 5HT.sub.1D receptors | Chemistry; Metallurgy | 17 | Expired |
| US5641779A | Selective ligands of 5-HT.sub.1D -5-HT.sub.1B receptors derived from indolepiperazine which are useful medicaments | Chemistry; Metallurgy | 16 | Expired |
| US5948806A | Treatment of Parkinson's disease with (+)2-(ethyl-2,3-dihydrobenzofuranyl)-2-Imidazoline (dexefaroxan or (+) efaroxan) | Human Necessities | 4 | Expired |
| US5661172A | Use of efaroxan and derivatives thereof for the treatment of Alzheimer's disease | Human Necessities | 3 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.